|
|
News Breaks | | | | October 8, 2012 | | 09:01 EDT |  | LIFE | Life Technologies acquires Compendia Bioscience
Life Technologies announced the acquisition of Compendia Bioscience, a cancer bioinformatics company widely used by the pharmaceutical industry to identify novel gene targets for drug discovery and development. Its deep oncology expertise and high-value, proprietary assets enhance Life's diagnostic development capabilities across multiple platforms, including next-generation sequencing, qPCR and proteome analysis. The financial terms of the deal are not being disclosed. The acquisition of Compendia Bioscience is expected to be neutral to 2012 earnings and accretive to the company's overall ROIC by 2015. | |
|
News For LIFE From The Last 14 Days Check below for free stories on LIFE the last two weeks. |
|
|
| June 19, 2013 | | 08:02 EDT | | LIFE | Life Technologies signs licensing agreement with Suzhou Ribo Life Sciences
 Subscribe for More Information | | | June 13, 2013 | | 08:01 EDT | | LIFE | Life Technologies acquires Life Science Korea
Subscribe for More Information | | | June 11, 2013 | | 13:34 EDT |  | LIFE | Options with increasing implied volatility: EBIX LIFE SFD
| | | June 10, 2013 | | 11:57 EDT | | LIFE | Options with increasing implied volatility: WM LIFE
| | | June 7, 2013 | | 12:04 EDT | | LIFE | Options with increasing implied volatility:TIBX RHT IRM CA LIFE
Subscribe for More Information | | | June 6, 2013 | | 08:38 EDT |  | LIFE | Thermo Fisher financing slightly higher than expected, says Leerink
Leerink says Thermo Fisher's (TMO) common stock offering of $2.5B to fund the Life Technologies (LIFE) deal came in slightly above its expectation of $2.1B. Further, the firm believes the second request for information from the FTC is not a surprise, and feels any required divestitures will not materially impact the financial profile of the combined company. Leerink keeps an Outperform rating on shares of Thermo Fisher. | | | 08:31 EDT | | LIFE | Thermo Fisher expects second FTC request over Life deal
Thermo Fisher (TMO) disclosed last night that it anticipates receiving on June 7, a request for additional information and documentary material, often referred to as a "Second Request," from the United States Federal Trade Commission in connection with the FTC’s Hart-Scott-Rodino regulatory review of its Life Technologies (LIFE) acquisition. The company added that it has been working, and will continue to work, cooperatively with the FTC and that it continues to expect the acquisition to close in early 2014. | |
|
|
|
|
|
|
